Advanced Search

Shrenuj Nears Debt Deal to Ease Liquidity Crisis

Nov 29, 2016 3:42 AM   By Rapaport News
Comment Comment Email Email Print Print Facebook Facebook Twitter Twitter Share Share

Shrenuj & Co. is close to securing at least $100 million in “long-term” funding from an unidentified institutional investor to ease the beleaguered company’s debt crisis.

The diamond and jewelry manufacturer will deploy the timely external financing to relieve pressure on liquidity, a source close to the talks told Rapaport News. Mumbai-based Shrenuj is in the final stages of preparing the financing deal, which is expected to be announced in mid-December.

Shrenuj has bank debts to the tune of $450 million, of which $35 million is overdue, the source said. A strain on liquidity has forced the company to downscale its diamond-cutting operations in Botswana while it also had its De Beers sightholder status suspended in July.

The company is “not repaying banks but bringing in fresh money to support growth and regularize the bank lines that have been impacted by slow recoveries from customers,” the source told Rapaport News in an email.

About a third of the funds will be used to “regularize" the lines of bank credit, which have been hit by delays in payments from Shrenuj’s customers. The rest will go toward restoring operational normalcy, including the manufacturing facilities, and business growth, the source said.

The company expects operations in Botswana will return to normal after the Christmas and New Year holiday season, Vishal Doshi, Shrenuj’s executive director, had said last week. That assumes the company manages to reach an agreement with De Beers to resume its supply of rough diamonds, Doshi pointed out.
Tags: Botswana, Debt, India, Manufacturing, mumbai, Rapaport News, Shrenuj, Shrenuj & Co, Vishal Doshi
Similar Articles
Comments: (0)  Add comment Add Comment
Arrange Comments Last to First
© Copyright 1978-2021 by Rapaport USA Inc. All rights reserved. Index®, RapNet®, Rapaport®, PriceGrid™, Diamonds.Net™, and JNS®; are registered TradeMarks.
While the information presented is from sources we believe reliable, we do not guarantee the accuracy or validity of any information presented by Rapaport or the views expressed by users of our internet service.